Company research
Connect Biopharma Holdings Ltd
CIK 1835268Updated Oct 7, 2026
SecurityCNTB · NASDAQ · equity
CNTB price & chart
Loading TradingView…
NASDAQ:CNTB on TradingView ↗In the news
Seeking Alpha
Connect Biopharma Holdings Limited (CNTB) Discusses Topline Results of Seabreeze STAT Study Evaluating Rademikibart for COPD Exacerbations - Slideshow ↗
Connect Biopharma Holdings Limited (CNTB) Discusses Topline Results of Seabreeze STAT Study Evaluating Rademikibart for COPD Exacerbations Transcript ↗
Connect Biopharma Holdings Limited (CNTB) Discusses Topline Results of Rademikibart Phase 2 Study for Acute Asthma Exacerbations Transcript ↗
Recent filings
SCHEDULE 13G - filed by BML Investment Partners, L.P. regarding Connect Biopharma Holdings Ltd
4 filing
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
SCHEDULE 13G/A - filed by Wei Zheng regarding Connect Biopharma Holdings Ltd
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 56,075,000Source | 101,284,000Source | 125,892,000Source | 174,013,000Source |
| Property, Plant and Equipment, NetUSD | 3,808,000Source | 4,048,000Source | 4,274,000Source | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 38,345,000Source | 78,232,000Source | — | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 13,000Source | 789,000Source | — | — |
| Assets, CurrentUSD | 50,929,000Source | 96,961,000Source | — | — |
| Prepaid Expense and Other Assets, CurrentUSD | 6,574,000Source | 2,464,000Source | — | — |
| Operating Lease, Right-of-Use AssetUSD | 647,000Source | 189,000Source | — | — |
| Other Assets, NoncurrentUSD | 646,000Source | 33,000Source | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 14,095,000Source | 9,118,000Source | 24,849,000Source | 16,521,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | — | — |
| Common Stock, Value, IssuedUSD | 10,000Source | 10,000Source | — | — |
| Additional Paid in CapitalUSD | 444,176,000Source | 439,357,000Source | — | — |
| Retained Earnings (Accumulated Deficit)USD | -400,835,000Source | -345,355,000Source | — | — |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,191,000Source | -1,666,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 41,980,000Source | 92,166,000Source | — | — |
| Liabilities and EquityUSD | 56,075,000Source | 101,284,000Source | — | — |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 13,613,000Source | 8,462,000Source | — | — |
| Operating Lease, Liability, CurrentUSD | 322,000Source | 154,000Source | — | — |
| Accounts Payable, CurrentUSD | 1,964,000Source | 342,000Source | — | — |
| Operating Lease, Liability, NoncurrentUSD | 368,000Source | 24,000Source | — | — |
| Other Liabilities, NoncurrentUSD | 114,000Source | — | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 11,160,000Source | 7,802,000Source | — | — |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 44,300,000Source | 93,700,000Source | — | — |
| DeferredTaxAssetsUSD | — | — | 0Source | 0Source |
| IssuedCapitalUSD | — | — | 10,000Source | 9,000Source |
| Short-term InvestmentsUSD | 5,997,000Source | 15,476,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or LossUSD | — | — | -59,503,000Source | -114,444,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 704,000Source | 660,000Source | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 3,726,000Source | 6,728,000Source | — | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -776,000Source | 789,000Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | 1,622,000Source | -1,867,000Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -51,206,000Source | -23,612,000Source | — | — |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 9,818,000Source | -3,451,000Source | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 434,000Source | 750,000Source | — | — |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,093,000Source | 227,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -39,887,000Source | -27,431,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 38,345,000Source | 78,232,000Source | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | — | 111,000Source | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 408,000Source | -595,000Source | — | — |
| Additional Financial Items | ||||
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | — | — | -4,277,000Source | 2,572,000Source |
| AdjustmentsForSharebasedPaymentsUSD | — | — | 3,259,000Source | 45,598,000Source |
| AdjustmentsForUnrealisedForeignExchangeLossesGainsUSD | — | — | -367,000Source | -9,629,000Source |
| Share-based Payment Arrangement, ExpenseUSD | 3,726,000Source | 6,728,000Source | — | — |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 44,300,000Source | 93,700,000Source | — | — |
| Debt Securities, Available-for-sale, Realized Gain (Loss)USD | 0Source | 0Source | — | — |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | 0Source | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -37,000Source | -9,000Source | — | — |
| General and Administrative ExpenseUSD | 20,340,000Source | 19,229,000Source | — | — |
| Income Tax Expense (Benefit)USD | 197,000Source | 223,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -55,480,000Source | -15,628,000Source | — | — |
| Nonoperating Income (Expense)USD | 2,791,000Source | 7,047,000Source | — | — |
| Operating ExpensesUSD | 58,138,000Source | 48,485,000Source | — | — |
| Operating Lease, ExpenseUSD | 500,000Source | 300,000Source | — | — |
| Other Nonoperating Income (Expense)USD | 523,000Source | 2,594,000Source | — | — |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | — | — | 290,000Source | 218,000Source |
| PaymentsToAcquireOrRedeemEntitysSharesUSD | — | — | 0Source | — |
| ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssetsUSD | — | — | 1,578,000Source | 5,907,000Source |
| Proceeds from Stock Options ExercisedUSD | 875,000Source | 194,000Source | — | — |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | — | — | 0Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 64,000Source | 26,033,000Source | — | — |
| Operating Income (Loss)USD | -58,074,000Source | -22,452,000Source | — | — |
| Other Nonoperating Income (Expense)USD | 523,000Source | 2,594,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -55,283,000Source | -15,405,000Source | — | — |
| Income Tax Expense (Benefit)USD | 197,000Source | 223,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -55,480,000Source | -15,628,000Source | — | — |
| Earnings Per Share, BasicUSD per share | -1Source | -0.28Source | — | — |
| Earnings Per Share, DilutedUSD per share | -1Source | -0.28Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 55,660,000Source | 55,213,000Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 55,660,000Source | 55,213,000Source | — | — |
| Additional Financial Items | ||||
| AdministrativeExpenseUSD | — | — | 14,515,000Source | 20,022,000Source |
| BasicEarningsLossPerShareUSD per share | — | — | -1.08Source | -2.1Source |
| DepreciationAndAmortisationExpenseUSD | — | — | 988,000Source | 6,940,000Source |
| DepreciationRightofuseAssetsUSD | — | — | 272,000Source | 2,019,000Source |
| DilutedEarningsLossPerShareUSD per share | — | — | -1.08Source | -2.1Source |
| EmployeeBenefitsExpenseUSD | — | — | 15,438,000Source | 143,819,000Source |
| ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD | — | — | 3,259,000Source | 45,598,000Source |
| ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsedUSD | — | — | 0Source | — |
| ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsedUSD | — | — | 0Source | — |
| FinanceCostsUSD | — | — | 23,000Source | 21,000Source |
| FinanceIncomeUSD | — | — | 2,714,000Source | 1,538,000Source |
| General and Administrative ExpenseUSD | 20,340,000Source | 19,229,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 747,000Source | 644,000Source | — | — |
| IncomeTaxExpenseContinuingOperationsUSD | — | — | 120,000Source | 292,000Source |
| InterestExpenseUSD | — | — | 23,000Source | 144,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | — | — | 23,000Source | 144,000Source |
| Nonoperating Income (Expense)USD | 2,791,000Source | 7,047,000Source | — | — |
| Operating ExpensesUSD | 58,138,000Source | 48,485,000Source | — | — |
| Operating Lease, ExpenseUSD | 500,000Source | 300,000Source | — | — |
| OtherIncomeUSD | — | — | 1,580,000Source | 924,000Source |
| ProfessionalFeesExpenseUSD | — | — | 7,545,000Source | 69,312,000Source |
| ProfitLossAttributableToOwnersOfParentUSD | — | — | -59,503,000Source | -114,444,000Source |
| ProfitLossBeforeTaxUSD | — | — | -59,383,000Source | -114,152,000Source |
| ProfitLossFromOperatingActivitiesUSD | — | — | -62,074,000Source | -115,669,000Source |
| Research and Development ExpenseUSD | 37,798,000Source | 29,256,000Source | 51,913,000Source | 93,646,000Source |